The 2020 Addictions and Their Treatment Course took place virtually in October 2020. Each presentation was pre-recorded and offered as a on-demand lecture. Registrants were encouraged to watch all on-demand lextures prior to attending a 1-day series of live Webinar discussions and Q&A sessions. During the live component, participants had the opportunity to interact with our expert presenters, who responded to questions and comments about topics relevant to the on-demand lectures.
This enduring material course includes all on-demand lectures, a recording of each Q&A session, and access to presentation slides.
There are no continuing education credits offered with this course material.
At the conclusion of this activity, participants should be able to:
AlcoholFaculty: Bryon Adinoff, MD
At the conclusion of this session, participants should be able to discuss the following aspects of alcohol use disorders:1. Historical aspects of the medical model.2. Diagnosis3. Drinking Guidelines4. Epidemiology5. Risk factors6. Pharmacology of alcohol7. Consequences of alcohol use on the brain8. The treatment of alcohol withdrawal and relapse
Behavioral AddictionsFaculty:Timothy Fong, MD
At the conclusion of this session, participants should be able to:1. State the clinical characteristics of gambling disorder and hypersexual disorder.2. Demonstrate improvement in screening and assessment techniques for behavioral disorders.3. Describe current treatment options.
Benzodiazepines: The Hidden EpidemicFaculty: Richard Ries, MD
At the conclusion of this session, participants should be able to:1. Define both therapeutic and potentially harmful uses of Benzodiazepines in medical treatment.2. Evaluate the risks of Benzodiazepine treatment.3. Utilize alternative agents when indicated.4. Differentiate toxicological urine screens utilized for Benzodiazepines.
CannabisFaculty: Petros Levounis, MD, MA
At the conclusion of this session, participants should be able to:1. List three intoxication symptoms and three withdrawal symptoms of cannabis.2. Discuss potentially beneficial uses of cannabinoids.3. Use effective psychosocial interventions to treat cannabis use disorder.4. Explain the increased dangerousness of synthetic cannabinoids.
Co-Morbidity of Substance and other Psychiatric DisordersFaculty: Edward Nunes, MD
At the conclusion of this seminar, participants should be able to:1. State the DSM-5 definitions of Substance Inducted disorders, how to distinguish substance induced from independent disorders, or substance intoxication or withdrawal, and how to apply this to history-taking and diagnostic formulation.2. Discuss the possible relationships between co-occurring substance and other mental disorders and how this informs diagnostic assessment.3. Describe the evidence from clinical trials on treatment of depression and other co-occurring mental disorders among patients with substance use disorders.
Emerging DrugsFaculty: Petros Levounis, MD, MA
At the conclusion of this session, participants should be able to:1. Identify emerging drugs on-the-basis of their chemical structure.2. Discuss the intoxication presentation of ecstasy, ketamine, and GHB.3. List one positive and one negative effect of each of the seven major emerging drugs of abuse.
Forensic Issues in AddictionFaculty:Laurence Westreich, MD
At the conclusion of this session, participants should be able to:1. Recognize the interactions between the legal process and addicted individuals.2. Describe the Landmark Supreme Court Cases in Addiction.3. Identify common criminal and civil matters, as related to addiction.4. Discuss the basics of the Forensic Psychiatric Evaluation and Testimony, especially as related to addiction.5. Formulate their own knowledge base and practice in the field of forensic addiction psychiatry.
General Concepts and EpidemiologyFaculty: Kevin Sevarino, MD, PhD
At the conclusion of this session, participants should be able to:1. Review the current working definitions of addiction.2. Describe the basic epidemiology of substance use disorders, including rates of use or misuse of the major classes of misused substances.3. Identify risk factors associated with development of substance use disorders.4. Discuss general concepts of treatment for substance use disorders.
Inequities in Addiction Treatment for Racial and Ethnic Minority PopulationsFaculty: Ayana Jordan, MD, PhD
At the conclusion of this session, participants should be able to:1. Describe the social and political factors that contribute to the existence and propagation of health disparities among racial and ethnic under-represented minority (URM) communities2. Describe culturally-informed treatment options that are being studied, which may be more acceptable to racial/ethnic URM populations3. Identify other substances commonly used in racial/ethnic minority communities that are largely unrecognized in the media
Medical Comorbidities in Patients with Substance Use DisordersFaculty: Steven Batki, MD
At the conclusion of this session, participants will be able to:1. Identify the main medical morbidities caused by alcohol, opioid, stimulant and tobacco use disorders.2. Discuss the epidemiology and basic features of HIV and HCV -- the main infectious diseases associated with injection drug use.3. Identify the key organ systems affected by alcohol, stimulants, and tobacco use disorders.
Motivational InterviewingFaculty: Carla Marienfeld, MD
At the conclusion of this session, participants should be able to:1. Describe and demonstrate the spirit of motivational interviewing (MI).2. Utilize the four processes (engaging, focusing, evoking, planning) of MI.3. Utilize patient-centered MI skills to help elicit and strengthen the internal motivation for change.
Naloxone Overdose TrainingFaculty: Michelle Lofwall, MD
At the conclusion of this session, participants should be able to:1. Describe the pharmacology and effectiveness of IV, IM, SC and IN naloxone for overdose reversal.2. Discuss with patients and their network supports on how to identify an opioid overdose, administer naloxone and activate EMS.
Neurobiology and GeneticsFaculty: Kevin Sevarino, MD, PhD
At the conclusion of this session, participants should be able to:1. Recognize animal models of addiction when encountered in the literature.2. Describe the basic neurocircuitry and neurochemistry of substance use disorders.3. Identify basic approaches to studying the genetics of addiction.4. Discuss epigenetic mechanisms implicated in addiction.
Pain and AddictionFaculty: Roger Chou, MD
At the conclusion of this session, participants should be able to:1. Review Historical Information: Context for the current epidemic of opioid misuse in the U.S.2. Describe the approach to the assessment and managing acute pain in high-risk patients.3. Identify the role of buprenorphine in treating pain and opioid use disorder.
Pregnancy and Substance Use DisordersFaculty: Michelle Lofwall, MD
At the conclusion of this session, participants should be able to:1. Describe the challenges in treating substance use disorder during pregnancy.2. Describe the comorbid conditions that may affect the health of mother and child.3. Describe information on treatment with a focus on Opioid Use Disorder.
Psychosocial Treatment of the AddictionsFaculty: Edward Nunes, MD
At the conclusion of this session, participants should be able to:1. List evidence-based behavioral treatments for substance use disorders.2. Describe the general principles and techniques involved in each of the behavioral treatments covered.3. Discuss the empirical evidence supporting the effectiveness of the behavioral treatments for substance use disorder.4. Describe the principles behind combining medications with behavioral therapies for treating substance use disorders, and list several combinations that have been studied.
Review of Opioids and Treatment of Opioid Use DisordersFaculty: John Renner Jr., MD
At the conclusion of this session, participants should be able to:1. Describe the epidemiology and neurobiology of opioid dependence.2. Describe the type of opioids and their effects.3. Describe the pharmacology of opioids.4. Describe the various treatment modalities for opioid dependence.5. Assess the treatment needs of pain patients and adolescents.
Sex and Drugs: Gender Differences in Substance Use DisordersFaculty: Kathleen Brady, MD, PhD
At the conclusion of this presentation, participants should be able to:1. Summarize prevalence of categories that influence SUDs for both genders.2. Describe the etiologic factors that influence SUDs among females and males.3. Compare the comorbidity differences between genders.4. Discuss the relationship between trauma and SUDs and how this relationship is impacted by gender.5. State the biologic influences of SUDs in both genders.6. Discuss gender-specific treatment implications.
Stimulant-Related DisordersFaculty: Steven Batki, MD
At the conclusion of this seminar, participants should be able to:1. Identify the main neurochemical effects of stimulants on brain monoamines.2. Recognize the main physical and behavioral effects of acute cocaine and methamphetamine intoxication and withdrawal.3. Identify the chief medical and psychiatric sequelae of chronic cocaine or methamphetamine use disorder.4. Identify 3 medications that have been tested in the treatment of cocaine or methamphetamine use disorder.
Substance Use Disorder Treatment in Hospital SettingsFaculty: Sanchit Marut, MD, MS
At the conclusion of this session, participants should be able to:1. Recognize how SUDs are diagnosed2. Discuss common hospital presentations of patients w/SUDs3. Describe strategies for assessing substance use with hospitalized patients4. Compare priorities of hospital care for: a. Alcohol: SBIRT, managing withdrawal, starting pharmacotherapy b. Nicotine: managing withdrawal, enhancing motivation c. Opioids: pain management, starting/continuing MAT5. Discuss effective responses to treatment-interfering behaviors6. Describe steps to help patients with SUDs access ongoing treatment
Substance Use Disorders in the Older PopulationFaculty: Louis Trevisan, MD
At the conclusion of this session, participants should be able to:1. Summarize the prevalence of substance use disorders in older Americans.2. Identify the signs and symptoms of an older person with a substance use disorder.3. Describe evidenced based treatments for the older person with a substance use disorder.
Suicide and Substance Use DisordersFaculty: Richard Ries, MD
At the conclusion of this session, participants should be able to:1. Differentiate key factors more associated with suicide vs overdose.2. Perform risk assessment for both suicide and overdose to improve patient care.3. Translate information from study evidence around both suicide and overdose into their daily clinical interviews and care planning.
TobaccoFaculty: Jill Williams, MD
At the conclusion of this session, participants should be able to:1. Recognize trends in current tobacco use.2. Describe the addicting effects of tobacco and it’s impact on health.3. Describe pharmacologic and non-pharmacologic treatment options.4. Discuss new products including e-cigarettes
Urine Drug TestingFaculty: Kevin Sevarino, MD, PhD
At the conclusion of this presentation, participants should be able to:1. Discuss clinical issues in performing urine drug testing (UDT).2. Describe the basic types of UDT and when they should be used.3. Define the metabolism of opioids and benzodiazepines in order to interpret UDT results.4. Describe the basic functions of a medical review officer and what a chain of custody entails.
Youth with Substance Use Disorders and Attention Deficit Hyperactivity DisorderFaculty: Amy Yule, MD
At the conclusion of this seminar, participants should be able to:1. Describe how developmental differences impact the assessment and treatment of youth with Substance Use Disorders (SUD).2. Assess Attention Deficit Hyperactivity Disorder (ADHD) in the context of a SUD.3. Treat ADHD when co-occurring with SUD.